The aforementioned increase in malonylation of glycolytic and gluconeogenic enzymes (G6PI, ALDOB, LDHA, FBP1, etc.)in diabetes suggests that Kmal may reprogram flux through these pathways (Zou et al. 2023). The gene discussed is FBP1; the disease is diabetes mellitus.